Kidney Stone Management Market Growth Drivers and Challenges:
Growth Drivers
- Technological advancements in robotic-assisted surgeries - Robotic systems provide surgeons with advanced capabilities, including improved dexterity and visualization during procedures such as percutaneous nephrolithotomy (PCNL). Such technological advancements have lucratively improved the efficiency of surgeries. Additionally, the increased precision that is offered by robotic-assisted surgeries not only enhances treatment outcomes but also contributes to faster recovery times and improved patient satisfaction. According to a report, in robotic surgeries, there is an observable success rate of more than 65% in surgical specialties like cardiology, gynecology, and urology. Moreover, the use of robotic-assisted surgeries in kidney stone management has witnessed promising results, with enhanced precision and reduced complication rates reported in comparison to traditional surgical approaches.
- Increase in kidney stones - Lifestyle factors such as poor dietary habits, and sedentary lifestyles, coupled with inadequate hydration are expected to the increased prevalence of kidney stones. As the occurrence of kidney stones becomes more common, there is a corresponding drive for advanced, effective management and treatment options. Moreover, according to the National Kidney Foundation, approximately 1 in 10 people will experience a kidney stone at some point in their lives, with the prevalence of kidney stones increasing over the past few decades. As people are becoming more aware of the risk factors, preventive measures, and available treatment options foster early detection and proactive management. This, in turn, is set to propel the reduction of severity and recurrence of kidney stone cases, positively augmenting the overall market size expansion. Regions with active kidney stone awareness and education programs reported a higher percentage of individuals adopting preventive measures, such as increased fluid intake, to reduce the risk of kidney stone formation.
- Increasing awareness and education programs - The implementation of awareness and education programs plays a vital role in driving the kidney stone management market. Increased awareness among the general population about the risk factors, preventive measures, and available treatment options fosters early detection and proactive management. This, in turn, contributes to a reduction in the severity and recurrence of kidney stone cases, positively impacting the overall market. Regions with active kidney stone awareness and education programs reported a higher percentage of individuals adopting preventive measures, such as increased fluid intake, to reduce the risk of kidney stone formation.
Challenges
- Recurrence and chronic nature of kidney stones- Kidney stones have a high recurrence rate, and individuals who have had stones have an increased risk of developing additional stones. The chronic nature of the condition requires a long-term management strategy, but due to limited treatment options availability for large stones may lead to prolonged and complex procedures, which increases the risk of complications and extended recovery periods.
- Limited treatment options availability that can hinder market growth
- Lack of universal guidelines remains a challenge
Kidney Stone Management Market Size and Forecast:
|
Base Year |
2025 |
|
Forecast Period |
2026-2035 |
|
CAGR |
5.5% |
|
Base Year Market Size (2025) |
USD 2.51 billion |
|
Forecast Year Market Size (2035) |
USD 4.29 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of kidney stone management is assessed at USD 2.63 billion.
The global kidney stone management market size was valued at over USD 2.51 billion in 2025 and is expected to expand at a CAGR of more than 5.5%, surpassing USD 4.29 billion revenue by 2035.
Asia Pacific kidney stone management market will dominate more than 47% share, propelled by a surge in aging population and advancements in kidney stone treatment technologies, forecast period 2026–2035.
Key players in the market include Siemens Healthineers AG, Medtronic plc, Lumenis, Cook Medical, Dornier MedTech GmbH, Richard Wolf GmbH, Stryker Corporation, Karl Storz SE & Co. KG, Allengers Medical Systems Limited, Terumo Corporation, Nipro Corporation, Olympus Corporation, JMS Co., Ltd. (Johnson Matthey Medical), NIKKISO CO., LTD.